U.S. Food and Drug Administration and European Medicines Agency Reach Landmark Decisions on Critical Path Institute’s Clinical Trial Simulation Tool for Alzheimer’s Disease
Best Practices for the Electronic Implementation of Clinical Outcome Assessment Response Scale Options
Development of a New Patient-Reported Outcome (PRO) Measure for Depression: Progress and Results from the PRO Consortium
January 6, 2013 ePRO Systems Validation: Clearly Defining The Roles Of Clinical Trial Teams And ePRO System Providers
Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure
Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure
